CST3 and coronary artery disorder: Some authors have described the prognostic benefit of cystatin C as marker of coronary artery disease severity and long-term mortality (both cardiovascular and non-cardiovascular) in populations with normal renal function16,17, even though therapeutics targeted at lowering circulating cystatin C are unlikely to be effective in preventing CVD9.